Table 4.

Antibody titer of oncologic patients according to several variables.

Variable	Antibody Titer (Median, IQR)
	After 1 Month	p Value	After 3 Months	p Value
Age (years)		0.018		0.004
<50	1530 (885–2605)		697 (452–840)
≥50	634 (298–844)		194 (115–373)
BMI (kg/m2)		0.016		0.156
<30	759 (406–1947)		232 (162–558)
≥30	264 (180–578)		170 (107–214)
Comorbidities		0.111		0.147
Yes	604 (322–780)		191 (120–400)
No	1060 (799–1925)		342 (203–697)
Progressive disease		0.592		0.681
Yes	726 (374–2340)		226 (104–669)
No	680 (353–917)		197 (169-364)
Chemotherapy in progress		0.871		0.186
Yes	734 (361–1675)		203 (102–426)
No	642 (332–1048)		340 (171–612)
FIGO stage		0.507		0.181
I	687 (549–814)		322 (200–464)
II	546 (265–1365)		285 (125–562)
III	782 (380–2287)		203 (167–608)
IV	422 (241–641)		86 (55–129)

BMI, body mass index; IQR, interquartile range.